학술논문

Neonatal Seizures: Providing Care With Evidence, Not Just Experience.
Document Type
Article
Source
Epilepsy Currents. Nov2021, Vol. 21 Issue 6, p427-429. 3p.
Subject
*EPILEPSY
*CRITICALLY ill children
*SEIZURES (Medicine)
*NEONATAL intensive care units
*NEONATAL mortality
*MEDICAL personnel
*PATIENTS' families
Language
ISSN
1535-7597
Abstract
B Safety of early discontinuation of antiseizure medication after acute symptomatic neonatal seizures b Glass HC, Soul JS, Chang T, et al. I JAMA Neurol i , 78(7): 817-825, 2021 ImportanceAntiseizure medication (ASM) treatment duration for acute symptomatic neonatal seizures is variable. ExposuresThe primary exposure was duration of ASM treatment dichotomized as ASM discontinued vs ASM maintained at the time of discharge from the neonatal seizure admission. Health care professionals are able to accurately identify only 50% of seizures, with poor inter-observer agreement.[2] Furthermore, electrographic-only seizures are common.[2] In the recent position paper by the ILAE Task Force on Neonatal Seizures, only clonic seizures could be reliably diagnosed clinically. [Extracted from the article]